CO4480026A1 - Nuevos compuestos que inhiben la accion de la lipoxigenasa y composiciones farmaceuticas que los contienen . . . - Google Patents
Nuevos compuestos que inhiben la accion de la lipoxigenasa y composiciones farmaceuticas que los contienen . . .Info
- Publication number
- CO4480026A1 CO4480026A1 CO95045652A CO95045652A CO4480026A1 CO 4480026 A1 CO4480026 A1 CO 4480026A1 CO 95045652 A CO95045652 A CO 95045652A CO 95045652 A CO95045652 A CO 95045652A CO 4480026 A1 CO4480026 A1 CO 4480026A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- halo
- cyano
- alkylene
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Abstract
UN COMPUESTO DE LA SIGUIENTE FORMULA QUIMICA: Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DEL MIS- MO, EN LOS QUE Ar1 ES UN RESTO HETEROCICLICO QUE SE SELECCIONA DEL GRUPO CONSISTENTE EN IMIDAZOLI- LO, PIRROLILO, PIRAZOLILO, 1,2,3-TRIAZOLILO, 1,2, 4-TRIAZOLILO, INDOLILO, INDAZOLILO Y BENCIMIDAZO- LILO, QUE ESTA UNIDO A X1 MEDIANTE UN ATOMO DE NI- TROGENO DEL ANILLO, Y QUE PUEDE ESTAR SUSTITUIDO OPCIONALMENTE CON UNO O DOS SUSTITUYENTES SELEC- CIONADOS DE HALO, HIDROXI, CIANO, AMINO, ALQUILO C1-4, ALCOXI C1-4, ALQUILTIO C1-4, ALQUILO C1-4, SUSTITUIDO CON HALO, ALCOXI C1-4 SUSTITUIDO CON HALO, ALQUILAMINO C1-4 Y DIALQUILAMINO C1-4; X1 ES UN ENLACE DIRECTO O ALQUILENO C1-4; Ar2 ES FENILO SUSTITUIDO OPCIONALMENTE CON UNO O DOS SUSTITUYENTES SELECCIONADOS DE HALO, HIDROXI, CIANO, AMINO, ALQUILO C1-4, ALCOXI C1-4, ALQUIL- TIO C1-4; ALQUILO C1-4 SUSTITUIDO CON HALO O ALCO- XI C1-4 SUSTITUIDO CON HALO: X2 ES -A-X o -X-A-, EN LOS QUE A ES UN ENLACE DI- RECTO O ALQUILENO C1-4 Y X ES OXI, TIO, SULFINILO O SULFONILO; Ar3 ES FENILO, PIRIDILENO, TIENILENO, FURILENO, OXAZOLILENO O TIAZOLILENO, SUSTITUIDOS OPCIONAL- MENTE CON UNO O DOS SUSTITUYENTES SELECCIONADOS DE HALO, HIDROXI, CIANO, AMINO, ALQUILO C1-4, AL- COXI C1-4, ALQUILTIO C1-4, ALQUILO C1-4, SUSTITUI- CO CON HALO ALQUILAMINO C1-4 Y DIALQUILAMINO C1-4; CADA R1 Y R2 SON ALQUILO C1-4 O JUNTOS FORMAN UN GRUPO DE FORMULA -D1-Z-D2- QUE, JUNTO CON EL ATOMO DE CARBONO AL QUE ESTAN UNIDOS, DEFINE UN ANILLO QUE TIENE 3 A 8 ATOMOS, EN EL DE D1 Y D2 SON AL- QUILENO C1-4 Y Z ES UN ENLACE DIRECTO U OXI, TIO, SULFINILO, SULFONILO O VINILENO, Y D1 Y D2 PUEDEN ESTAR SUSTITUIDOS CON ALQUILO C1-3; e Y es CONR3R4, CN, CPPR3, COR3 o CSNR3R4, EN LOS QUE CADA R3 Y R4 SON H O ALQUILO C1-4. FIGURA 1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9401747 | 1994-10-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4480026A1 true CO4480026A1 (es) | 1997-07-09 |
Family
ID=14098722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO95045652A CO4480026A1 (es) | 1994-10-18 | 1995-10-02 | Nuevos compuestos que inhiben la accion de la lipoxigenasa y composiciones farmaceuticas que los contienen . . . |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0787127B1 (es) |
JP (1) | JP3032579B2 (es) |
CN (1) | CN1093536C (es) |
AT (1) | ATE198474T1 (es) |
AU (1) | AU681520B2 (es) |
BG (1) | BG61768B1 (es) |
CA (1) | CA2202057C (es) |
CO (1) | CO4480026A1 (es) |
CZ (1) | CZ287350B6 (es) |
DE (1) | DE69519804T2 (es) |
DK (1) | DK0787127T3 (es) |
ES (1) | ES2153033T3 (es) |
FI (1) | FI971632A (es) |
GR (1) | GR3035471T3 (es) |
HU (1) | HU221543B (es) |
IL (1) | IL115581A (es) |
LV (1) | LV11468B (es) |
MY (1) | MY114680A (es) |
NO (1) | NO314629B1 (es) |
NZ (1) | NZ285163A (es) |
PE (1) | PE49196A1 (es) |
PL (1) | PL180104B1 (es) |
RU (1) | RU2136666C1 (es) |
SI (1) | SI9500392A (es) |
SK (1) | SK281577B6 (es) |
TR (1) | TR199501274A2 (es) |
TW (1) | TW411339B (es) |
UA (1) | UA45312C2 (es) |
WO (1) | WO1996011911A1 (es) |
YU (1) | YU65995A (es) |
ZA (1) | ZA958748B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6239285B1 (en) | 1998-02-06 | 2001-05-29 | Pfizer Inc | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
US6194585B1 (en) * | 1998-12-22 | 2001-02-27 | Pfizer Inc. | Process for preparing 5-lipoxygenase inhibitors |
US6346624B1 (en) * | 1999-08-31 | 2002-02-12 | Pfizer Inc | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
SG87145A1 (en) * | 1999-08-31 | 2002-03-19 | Pfizer Prod Inc | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
US6344563B1 (en) * | 1999-08-31 | 2002-02-05 | Timothy Norris | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
PL214230B1 (pl) * | 2000-03-24 | 2013-07-31 | Euro Celtique Sa | Podstawione arylem pirazole i triazole, kompozycja farmaceutyczna je zawierajaca oraz ich zastosowanie |
DK1383874T3 (da) * | 2001-04-20 | 2010-05-03 | Novozymes As | Varianter af lipogygenase og deres anvendelse |
GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
NZ576376A (en) * | 2006-11-27 | 2011-02-25 | Pfizer Prod Inc | Pyrazole analogs |
EP2225229A1 (en) * | 2007-11-26 | 2010-09-08 | Pfizer Inc. | Pyrazole derivatives as 5-lo inhibitors |
WO2013128378A1 (en) * | 2012-02-28 | 2013-09-06 | Piramal Enterprises Limited | Phenyl alkanoic acid derivatives as gpr agonists |
IL277071B1 (en) | 2018-03-08 | 2024-03-01 | Incyte Corp | Aminopyrizine diol compounds as PI3K–y inhibitors |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0462830B1 (en) * | 1990-06-21 | 1995-10-18 | Zeneca Limited | Cyclic ether derivatives |
IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
EP0505122A1 (en) * | 1991-03-21 | 1992-09-23 | Zeneca Limited | Alpha, alpha-dialkylbenzyl derivatives |
EP0540165A1 (en) * | 1991-10-03 | 1993-05-05 | Zeneca Limited | Alkanoic acid derivatives |
KR100190728B1 (ko) * | 1993-06-14 | 1999-06-01 | 디. 제이. 우드, 스피겔 알렌 제이 | 이미다졸 리폭시게나제 저해제 |
-
1994
- 1994-10-18 SK SK1287-95A patent/SK281577B6/sk unknown
-
1995
- 1995-05-29 CA CA002202057A patent/CA2202057C/en not_active Expired - Fee Related
- 1995-05-29 ES ES95918121T patent/ES2153033T3/es not_active Expired - Lifetime
- 1995-05-29 AU AU24174/95A patent/AU681520B2/en not_active Ceased
- 1995-05-29 EP EP95918121A patent/EP0787127B1/en not_active Expired - Lifetime
- 1995-05-29 JP JP8513058A patent/JP3032579B2/ja not_active Expired - Fee Related
- 1995-05-29 PL PL95319727A patent/PL180104B1/pl not_active IP Right Cessation
- 1995-05-29 CN CN95195926A patent/CN1093536C/zh not_active Expired - Fee Related
- 1995-05-29 DE DE69519804T patent/DE69519804T2/de not_active Expired - Fee Related
- 1995-05-29 NZ NZ285163A patent/NZ285163A/en unknown
- 1995-05-29 HU HU9701853A patent/HU221543B/hu not_active IP Right Cessation
- 1995-05-29 AT AT95918121T patent/ATE198474T1/de not_active IP Right Cessation
- 1995-05-29 RU RU97106099/04A patent/RU2136666C1/ru not_active IP Right Cessation
- 1995-05-29 DK DK95918121T patent/DK0787127T3/da active
- 1995-05-29 CZ CZ19971177A patent/CZ287350B6/cs not_active IP Right Cessation
- 1995-05-29 WO PCT/IB1995/000408 patent/WO1996011911A1/en active IP Right Grant
- 1995-09-12 TW TW084109522A patent/TW411339B/zh not_active IP Right Cessation
- 1995-10-02 CO CO95045652A patent/CO4480026A1/es unknown
- 1995-10-12 IL IL11558195A patent/IL115581A/xx not_active IP Right Cessation
- 1995-10-13 UA UA95104510A patent/UA45312C2/uk unknown
- 1995-10-16 MY MYPI95003103A patent/MY114680A/en unknown
- 1995-10-17 ZA ZA958748A patent/ZA958748B/xx unknown
- 1995-10-17 YU YU65995A patent/YU65995A/sh unknown
- 1995-10-17 LV LVP-95-313A patent/LV11468B/en unknown
- 1995-10-17 PE PE1995282113A patent/PE49196A1/es not_active Application Discontinuation
- 1995-10-17 SI SI9500392A patent/SI9500392A/sl unknown
- 1995-10-18 TR TR95/01274A patent/TR199501274A2/xx unknown
- 1995-10-18 BG BG100070A patent/BG61768B1/bg unknown
-
1997
- 1997-04-17 NO NO19971773A patent/NO314629B1/no unknown
- 1997-04-17 FI FI971632A patent/FI971632A/fi not_active IP Right Cessation
-
2001
- 2001-02-23 GR GR20010400310T patent/GR3035471T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4480026A1 (es) | Nuevos compuestos que inhiben la accion de la lipoxigenasa y composiciones farmaceuticas que los contienen . . . | |
DE60017582D1 (de) | Tricyclische derivate der pyrazolcarbonsäure, ihre herstellung und sie enthaltende pharmazeutische zubereitungen | |
EP0629622A4 (es) | ||
NO913750L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
IL88901A (en) | Substituted 1,2,3-triazole, 1,2,4-triazole, pyrazole and pyrrole derivatives, their preparation and pharmaceutical compositions containing them | |
KR920701167A (ko) | 약제학적 활성 화합물 | |
DK0418845T3 (da) | Pyrazolderivater, fremgangsmåder til fremstilling deraf og farmaceutisk præparat omfattende samme | |
CZ20013522A3 (cs) | Sloučeniny inhibující adhezi buněk vykazující protizánětlivé a imunosupresivní účinky | |
TR199901468T2 (xx) | Alfa-2 adrenosept�r agonistleri olarak yararl� guanidinil heterosikl bile�ikleri. | |
RU97106099A (ru) | Ингибиторы 5-липоксигеназы | |
IL77151A0 (en) | Triazole derivatives,their use as fungicides and pharmaceutical compositions containing them | |
MX9702814A (es) | Inhibidores de la 5-lipoxigenasa. | |
CA2160140A1 (en) | Cycloalkylhydroxyureas and Their Use As Lipoxygenase Inhibitors | |
CA2232267A1 (en) | Novel imidazole lipoxygenase inhibitors | |
KR970707099A (ko) | 5-리폭시게나제 저해제(5-lipoxygenase inhibitors) | |
EP0420086A3 (en) | Pyrimidoindole derivatives and processes for preparation thereof | |
JO1814B1 (en) | Therapeutic agents | |
TH23886B (th) | ตัวขัดขวาง 5-ลิปอกซีจีเนส |